Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,982.28 (-1.09%)
DOW   33,992.92 (-1.03%)
QQQ   285.01 (-0.67%)
AAPL   145.32 (-1.88%)
MSFT   243.01 (-1.81%)
META   109.50 (-1.71%)
GOOGL   96.58 (-0.90%)
AMZN   94.79 (+1.48%)
TSLA   188.03 (+2.83%)
NVDA   161.05 (-1.01%)
NIO   10.31 (+1.38%)
BABA   75.89 (+0.52%)
AMD   73.67 (-1.96%)
T   18.86 (-1.36%)
MU   56.35 (-3.53%)
CGC   3.44 (-6.01%)
F   13.76 (-2.27%)
GE   86.66 (-1.68%)
DIS   96.49 (-2.41%)
AMC   7.30 (-2.80%)
PYPL   80.78 (+0.87%)
PFE   49.43 (+0.45%)
NFLX   284.53 (-0.35%)
S&P 500   3,982.28 (-1.09%)
DOW   33,992.92 (-1.03%)
QQQ   285.01 (-0.67%)
AAPL   145.32 (-1.88%)
MSFT   243.01 (-1.81%)
META   109.50 (-1.71%)
GOOGL   96.58 (-0.90%)
AMZN   94.79 (+1.48%)
TSLA   188.03 (+2.83%)
NVDA   161.05 (-1.01%)
NIO   10.31 (+1.38%)
BABA   75.89 (+0.52%)
AMD   73.67 (-1.96%)
T   18.86 (-1.36%)
MU   56.35 (-3.53%)
CGC   3.44 (-6.01%)
F   13.76 (-2.27%)
GE   86.66 (-1.68%)
DIS   96.49 (-2.41%)
AMC   7.30 (-2.80%)
PYPL   80.78 (+0.87%)
PFE   49.43 (+0.45%)
NFLX   284.53 (-0.35%)
S&P 500   3,982.28 (-1.09%)
DOW   33,992.92 (-1.03%)
QQQ   285.01 (-0.67%)
AAPL   145.32 (-1.88%)
MSFT   243.01 (-1.81%)
META   109.50 (-1.71%)
GOOGL   96.58 (-0.90%)
AMZN   94.79 (+1.48%)
TSLA   188.03 (+2.83%)
NVDA   161.05 (-1.01%)
NIO   10.31 (+1.38%)
BABA   75.89 (+0.52%)
AMD   73.67 (-1.96%)
T   18.86 (-1.36%)
MU   56.35 (-3.53%)
CGC   3.44 (-6.01%)
F   13.76 (-2.27%)
GE   86.66 (-1.68%)
DIS   96.49 (-2.41%)
AMC   7.30 (-2.80%)
PYPL   80.78 (+0.87%)
PFE   49.43 (+0.45%)
NFLX   284.53 (-0.35%)
S&P 500   3,982.28 (-1.09%)
DOW   33,992.92 (-1.03%)
QQQ   285.01 (-0.67%)
AAPL   145.32 (-1.88%)
MSFT   243.01 (-1.81%)
META   109.50 (-1.71%)
GOOGL   96.58 (-0.90%)
AMZN   94.79 (+1.48%)
TSLA   188.03 (+2.83%)
NVDA   161.05 (-1.01%)
NIO   10.31 (+1.38%)
BABA   75.89 (+0.52%)
AMD   73.67 (-1.96%)
T   18.86 (-1.36%)
MU   56.35 (-3.53%)
CGC   3.44 (-6.01%)
F   13.76 (-2.27%)
GE   86.66 (-1.68%)
DIS   96.49 (-2.41%)
AMC   7.30 (-2.80%)
PYPL   80.78 (+0.87%)
PFE   49.43 (+0.45%)
NFLX   284.53 (-0.35%)
NASDAQ:ADXS

Advaxis - ADXS Stock Forecast, Price & News

$1.70
-0.06 (-3.41%)
(As of 11/25/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.65
$1.70
50-Day Range
N/A
52-Week Range
$1.02
$33.60
Volume
835 shs
Average Volume
5,625 shs
Market Capitalization
$3.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ADXS stock logo

About Advaxis (NASDAQ:ADXS) Stock

Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. The company has collaborations and partnerships with Merck & Co., Inc.; OS Therapies, LLC; Aratana Therapeutics Inc.; Biocon Limited; Global BioPharma Inc.; Knight Therapeutics Inc; and others. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey.

Receive ADXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advaxis and its competitors with MarketBeat's FREE daily newsletter.

ADXS Stock News Headlines

StockNews.com Initiates Coverage on Advaxis (NASDAQ:ADXS)
See More Headlines
Receive ADXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advaxis and its competitors with MarketBeat's FREE daily newsletter.

ADXS Company Calendar

Today
11/28/2022
Fiscal Year End
10/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ADXS
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-17,860,000.00
Pretax Margin
-6,064.80%

Debt

Sales & Book Value

Annual Sales
$3.24 million
Book Value
$21.36 per share

Miscellaneous

Free Float
1,811,000
Market Cap
$3.09 million
Optionable
Not Optionable
Beta
2.17

Key Executives

  • Mr. Kenneth A. Berlin J.D. (Age 58)
    Pres & CEO
    Comp: $625.4k
  • Mr. Igor Gitelman CPA (Age 46)
    CPA, M.B.A., MBA, Chief Accounting Officer, Interim CFO & VP of Fin.
    Comp: $297.87k
  • Dr. Andres A. Gutierrez M.D. (Age 61)
    Ph.D., Exec. VP & Chief Medical Officer
    Comp: $472.03k













ADXS Stock - Frequently Asked Questions

How have ADXS shares performed in 2022?

Advaxis' stock was trading at $1.91 at the start of the year. Since then, ADXS stock has decreased by 11.0% and is now trading at $1.70.
View the best growth stocks for 2022 here
.

What other stocks do shareholders of Advaxis own?
What is Advaxis' stock symbol?

Advaxis trades on the NASDAQ under the ticker symbol "ADXS."

How do I buy shares of Advaxis?

Shares of ADXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Advaxis' stock price today?

One share of ADXS stock can currently be purchased for approximately $1.70.

How much money does Advaxis make?

Advaxis (NASDAQ:ADXS) has a market capitalization of $3.09 million and generates $3.24 million in revenue each year. The company earns $-17,860,000.00 in net income (profit) each year or ($8.93) on an earnings per share basis.

How can I contact Advaxis?

Advaxis' mailing address is 9 DEER PARK DRIVE SUITE K-1, MONMOUTH JUNCTION NJ, 08852. The official website for the company is www.advaxis.com. The company can be reached via phone at 609 452 9813, via email at tim@lifesciadvisors.com, or via fax at 609-452-9818.

This page (NASDAQ:ADXS) was last updated on 11/28/2022 by MarketBeat.com Staff